IP Library Granted Patent US 12,391,911
Granted Patent B2
US 12,391,911 · App. 18/441,106 · Granted Aug 19, 2025

Adherent cell culture substrate sampling device

Inventors: Vesa Turkki (Kuopio, FI); Nigel Parker (Chinnor, GB)
Assignee: TRIZELL LTD.
C12M37/04C12M21/08C12M23/14C12M23/28C12M25/00C12M25/02C12M29/00C12N5/0068
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,391,911
App. No.
18/441,106
Granted
Aug 19, 2025
Kind
B2
Abstract

A device for aseptically obtaining a physical sample of an adherent cell culture substrate from an adherent cell culture bioreactor. This enables the operator to directly evaluate e.g., cell density/confluence on the substrate without contaminating the cell culture.

Claims (17)

1. An apparatus for aseptically obtaining a sample of a solid substrate for adherent cell culture contained in the interior of a bioreactor container, the apparatus comprising:

a sampling device housing having a sampling device housing exterior and a sampling device housing interior, the sampling device housing configured to be disposable on the port of an adherent cell culture bioreactor so that the sampling device housing interior can be in aseptic communication with the bioreactor container interior via the port,

the sampling device housing interior housing a solid substrate sampling device configured to obtain a sample of solid substrate for adherent cell culture contained in the bioreactor container interior,

the solid substrate sampling device disposed in the sampling device housing interior whereby the solid substrate sampling device can aseptically obtain a sample of solid substrate for adherent cell culture contained in the interior of the bioreactor container.

2. The apparatus of claim 1 , wherein the sampling device is selected from the group consisting of tweezers, forceps, suction device and hook.

3. The apparatus of claim 2 , wherein the sampling device housing comprises a tube and the sampling device comprises tweezers.

4. The apparatus of claim 2 , wherein the sampling device housing comprises a bag and the sampling device comprises foreign body forceps.

5. A method for aseptically taking a sample of an adherent cell culture substrate, the method comprising:

obtaining the apparatus of claim 1 , wherein the apparatus container interior aseptically contains liquid cell culture media and a solid substrate for adherent cell culture;

using the sampling device to aseptically obtain a sample of the solid substrate for adherent cell culture; and

aseptically detaching the sampling device housing from the port.

6. A method for producing a cell culture product, the method comprising:

obtaining the apparatus of claim 1 , wherein the apparatus container interior aseptically contains liquid cell culture media and a solid substrate for adherent cell culture;

culturing a cell culture in the liquid cell culture media;

using a sampling device to aseptically obtain a sample of the solid substrate for adherent cell culture;

analyzing the sample to confirm the presence of a cell culture product;

and obtaining the cell culture product.

Assignments (3)
CHANGE OF NAME Recorded Jul 10, 2025
From: TRIZELL LTD
To: FERRING VENTURES LTD
Reel/Frame 071655/0966 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2024
From: TURKKI, VESA
To: TRIZELL LTD.
Reel/Frame 067130/0503 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2024
From: PARKER, NIGEL
To: TRIZELL LTD.
Reel/Frame 067130/0768 →
Continuity (3)
Continuation 15763123
Provisional Application 62419613 · Nov 9, 2016
Related Publication 20240263125A1 · Aug 8, 2024
References Cited (23)
US 5601757A · Biselli et al. · 1997 [cited by applicant]
US 10851341B2 · Kasuto et al. · 2020 [cited by applicant]
US 11932843B2 · Turkki · 2024 [cited by examiner]
US 20050101008A1 · Diresta · 2005 [cited by applicant]
US 20100099127A1 · Bodner · 2010 [cited by applicant]
US 20100248370A1 · Moynahan · 2010 [cited by applicant]
US 20120052565A1 · DeRosa et al. · 2012 [cited by applicant]
US 20130071872A1 · Ho et al. · 2013 [cited by applicant]
US 20140170644A1 · Hadayer et al. · 2014 [cited by applicant]
US 20170114315A1 · Yokoo · 2017 [cited by applicant]
CN 102994377A · 2013 [cited by applicant]
CN 103476924A · 2013 [cited by applicant]
EP 1637584A1 · 2006 [cited by applicant]
KR 1020050017761A · 2005 [cited by applicant]
RU 130077U1 · 2013 [cited by applicant]
SU 1682858A1 · 1991 [cited by applicant]
WO 2001008630A1 · 2001 [cited by applicant]
WO 2005124310A1 · 2005 [cited by applicant]
WO 2016091744A1 · 2016 [cited by applicant]
Hanna P. Lesch, et al., Process Development of Adenoviral Vector Production in Fixed Bed Bioreactor: From Bench to Commercial Scale. Human Gene Therapy. Aug. 2015. 560-571. Published Online: Jul. 14, 2015 https://doi.or… [cited by applicant]
Merten, Otto-Wilhelm. “Manufacturing of viral vectors for gene therapy: part I. Upstream processing.” Future Science, Pharm. Bioprocess. 2014. 2(2). 183-203. [cited by applicant]
International Search Report for PCT/IB2017/057008, mailed Jan. 26, 2018. [cited by applicant]
Written Opinion for International Application No. PCT/IB2017/057008, mailed Jan. 26, 2018. [cited by applicant]